Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist
作者:Qingmei Hong、Raman K. Bakshi、Brenda L. Palucki、Min K. Park、Zhixiong Ye、Shuwen He、Patrick G. Pollard、Iyassu K. Sebhat、Jian Liu、Liangqin Guo、Doreen E. Cashen、William J. Martin、David H. Weinberg、Tanya MacNeil、Rui Tang、Constantin Tamvakopoulos、Qianping Peng、Randy R. Miller、Ralph A. Stearns、Howard Y. Chen、Airu S. Chen、Alison M. Strack、Tung M. Fong、D. Euan MacIntyre、Matthew J. Wyvratt、Ravi P. Nargund
DOI:10.1016/j.bmcl.2011.02.090
日期:2011.4
We report the discovery of piperazine urea based compound 1, a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist. Compound 1 shows anti-obesity efficacy without potentiating erectile activity in the rodent models. (C) 2011 Elsevier Ltd. All rights reserved.